Form D · Other
Axicon Labs Inc.
Brookline, MA · CIK 0001952594
Offering snapshot reported Jan 29, 2024 · SEC filing
- Reported sold
- $11.5M Offering amount: $11.5M
- Investors reported
- 46 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 13, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 29, 2024 | Initial | $11,499,978 | No comparison | 46 | SEC filing |
| Nov 14, 2022 | Initial | $4,500,000 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-503773
$4,500,000.00 of the Total Amount Sold was purchased through the conversion of indebtedness.
Source: Form D, filed Jan 29, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jesper Kristensen | Director, Executive, Promoter |
| Guillaume Lambert | Director, Executive |
| Rui Zhang | Director |
Issuer details
Industry: Other (See others in industry)
Address:
202 Washington Street Suite 334
Brookline, MA, 02445
Brookline, MA, 02445